Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Prostatic Neoplasms 7Breast Neoplasms 3Triple Negative Breast Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplastic Syndromes, Hereditary 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Sarcoma 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Lymphoproliferative Disorders 1Kidney Neoplasms 1Hereditary Breast and Ovarian Cancer Syndrome 1Hematologic Neoplasms 1Endometrial Neoplasms 1Cytopenia 1Congenital Bone Marrow Failure Syndromes 1Colorectal Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Cancer Risk Syndrome 1Breast Neoplasms, Male 1Bone Marrow Failure Disorders 1

Interventions

Dexamethasone 238Lenalidomide 145daratumumab 123Bortezomib 101pomalidomide 86Calcium Dobesilate 76carfilzomib 74Cyclophosphamide 70Specimen Handling 42isatuximab 40Biopsy 40fludarabine 36belantamab mafodotin 36Magnetic Resonance Spectroscopy 35talquetamab 29dexamethasone acetate 27dexamethasone 21-phosphate 27Melphalan 27auricularum 26iberdomide 25ixazomib 22fludarabine phosphate 22selinexor 21elotuzumab 21Whole-Body Irradiation 14X-Rays 13tocilizumab 12venetoclax 11Mycophenolic Acid 10trametinib 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multiple Myeloma × Genetic Counseling × 1 year × Clear all
NCT06630104 2026-01-08

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Mayo Clinic

Phase NA Recruiting
82 enrolled
LymphoidPlasma cell

Lymphoproliferative Disorders, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡